Evaluation the Invader Assay with the BACTEC MGIT 960 System for ...

3 downloads 53683 Views 147KB Size Report
Aug 8, 2007 - Mailing address: Department of Microbiology, BML, Inc., 1361–1 ..... equipment, such as automated DNA sequencer or no exclusive workspace ...
JCM Accepts, published online ahead of print on 8 August 2007 J. Clin. Microbiol. doi:10.1128/JCM.02289-06 Copyright © 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

1

Evaluation the Invader Assay with the BACTEC MGIT 960 System for Prompt Isolation

2

and Identification of Mycobacteria from Clinical Specimens

3 4

D E

5

Sadahiro Ichimura1, 3, Makoto Nagano2, Nobuko Ito2, Masahiro Shimojima1, Toru Egashira2,

6

Chikara Miyamoto2, Kiyofumi Ohkusu3, and Takayuki Ezaki3

T P

7 8 9

1

E C

Department of Microbiology, BML, Inc., 2Division of Advanced Technology, BML, Inc., 1361–1

10

Matoba, Kawagoe, Saitama 350–1101, Japan;

11

3

12

Graduate School of Medicine, Gifu, Gifu 501–1194, Japan

13 14

Department of Microbiology, Regeneration and Advanced Medical Science, Gifu University

C A

15

*Corresponding author. Mailing address: Department of Microbiology, BML, Inc., 1361–1

16

Matoba,

17

+81–049–232–0529. E–mail: ichi–[email protected].

Kawagoe,

Saitama

350–1101,

Japan.

Phone:

+81–049–232–0940.

18 19 20

Running title: IDENTIFYING MYCOBACTERIA BY INVADER ASSAY

21 22

Key words: mycobacteria, MGIT, 16S rDNA, ITS-1 region, Invader assay 1

Fax:

23

ABSTRACT

24 25

Rapid and accurate identification of mycobacterial species is essential for patient management.

26

This study describes the use of the Invader assay in conjunction with the BACTEC MGIT 960

27

system that provides an efficient procedure in clinical use. This assay discriminates single–base

28

differences (e.g., genotyping single nucleotide polymorphisms) under homogeneous and

29

isothermal conditions, and can measure directly on genomic DNA without prior target DNA

30

amplification. To identify a wide variety of mycobacterial species, 20 Invader probes were

31

designed to target the 16S rRNA gene (16S rDNA) and the 16S–23S rRNA gene internal

32

transcribed spacer 1 (ITS-1) region. To validate the Invader probes, we used 78 ATCC strains,

33

and 607 clinical mycobacterial strains, which were identified by DNA sequencing of the 16S

34

rDNA and ITS-1. The Invader assay could accurately identify and differentiate these strains

35

according to target sequences. Besides, it could detect and identify 116 (95.1%) of 122 positive

36

liquid cultures from the BACTEC MGIT 960 system, and did not react to 83 contaminated

37

MGIT cultures. Species identification takes 6.5 h with the Invader assay: 2.0 h for DNA

38

extraction, 0.5 h for handling, and up to 4 h for the Invader reaction. The Invader assay has the

39

speed, ease of use, and the accuracy to be an effectively procedure for bacteriological diagnosis

40

of mycobacterial infections.

D E

T P

E C

C A

41

2

42

INTRODUCTION

43 44

Rapid and accurate identification of mycobacteria is essential for determining appropriate

45

therapies and for epidemiological studies (7, 11, 14, 37). For example, the U.S. Centers for

46

Disease Control and Prevention (CDC) recommends turnaround times of 2–3 weeks for

47

processing of Mycobacterium tuberculosis (4, 33, 36). A definitive diagnosis of mycobacterial

48

infection depends on growth and identification of the bacteria (2, 3). To speed the bacterial

49

culturing, time-consuming cultures on egg-based solid media, such as Löwenstein–Jensen (LJ)

50

and Ogawa slants, are being replaced by faster liquid culture methods, such as the BACTEC

51

MGIT 960 system (Becton Dickinson, Sparks, MD) and the MB/BacT system (Organon Teknika,

52

Boxtel, The Netherlands) (1, 13, 15, 21, 22, 33).

D E

T P

E C

C A

53

Now a method is urgently needed to rapidly identify a wide variety of Mycobacterium species

54

directly from liquid cultures. Unfortunately, the available methods have several limitations. For

55

example, the widely used AccuProbe system (GenProbe, San Diego, CA) (8, 21, 25, 29)

56

identifies only a limited number of the many mycobacterial species seen in a clinical laboratory.

57

While much faster and more accurate, DNA sequencing (16, 26, 39), PCR restriction fragment

58

length–polymorphism (RFLP) assays (6, 28, 35) and InnoLiPA Mycobacteria (Innogenetics,

59

Ghent, Belgium) (23, 38) require expensive equipment and an exclusive workspace for PCR. In

60

addition, DNA sequencing and PCR–RFLP require pure cultures, and if the sample was the

61

mixed culture, separate culture on a solid medium would further slow these assays.

62

Many routine procedures in clinical laboratories have been simplified by homogeneous

63

fluorescent detection systems. Here we report our study of one of these, the Invader assay (Third 3

64

Wave Technologies, Madison, WI) (17). The Invader assay can accurately discriminate

65

single–base differences, such as single nucleotide polymorphisms (SNPs), and can measure

66

directly on genomic DNA without prior target amplification. We evaluated the suitability of the

67

Invader assay for directly identifying mycobacteria from the MGIT 960 system.

D E

68

T P

E C

C A

4

69

MATERIALS AND METHODS

70

Bacterial strains. The validation of the Invader probes was performed by testing 78 ATCC

71

strains (Table 2), and 607 clinical mycobacterial strains (Table 3), which were identified and

72

confirmed the target sequences by DNA sequencing of the 16S rDNA and ITS-1. These clinical

73

strains cultured on Ogawa slants mainly for NTM (nontuberculous mycobacterium) infections

74

were tested in the BML General Laboratory from December 2003 to June 2005 (excluding

75

overlapping patients).

76

Clinical specimens for the BACTEC MGIT 960 system. Between November 21 and

77

November 25, 2004, 1390 consecutive clinical specimens were received for routine

78

mycobacterial detection in the BML General Laboratory. These included 1040 sputum and 155

79

other respiratory specimens, 28 digestive samples, 15 sterile body fluids, 14 urine samples, 6

80

wound samples, and 132 samples from unspecified sources.

81

Inoculation and cultivation of clinical specimens. Before inoculation, the MGIT 960 tubes

82

were prepared as described by the manufacturer (Becton Dickinson). A 0.5 ml portion of the

83

processed specimen was inoculated into the MGIT, and the tubes were introduced into the MGIT

84

960 instrument and incubated until they were found to be positive by the instrument or for 42

85

days. A 0.1-ml portion of the processed specimen was inoculated onto a solid slant of Ogawa egg

86

medium (Kyokuto Pharmaceutical, Tokyo, Japan), and the slants were incubated in 5–10% CO2.

87

For 56 days, the growth on the slants was examined for visible colonies. All positive media were

88

examined by Ziehl–Neelsen and gram staining to confirm the presence of only acid–fast bacteria,

89

and the colonies were subcultured onto trypticase soy agar II with 5% sheep blood (TSA II;

90

Becton Dickinson) to check for contaminants.

D E

T P

E C

C A

5

91

DNA extraction. For Ogawa slants, a sample of DNA was extracted from a loopful (3–mm3

92

sphere) of bacterial colony. Bacterial cells were mechanically disrupted with glass beads. After

93

phenol-chloroform treatment (DDH Mycobacteria; Kyokuto Pharmaceuticals), DNA in the

94

aqueous phase was extracted and purified on a robotic liquid handler AGE-96 (Biotec, Tokyo,

95

Japan) with magnetic silica particles (MagneSil Blood Genomic Max Yield System; Promega,

96

Madison, WI). For the MGIT 960 system, a 4.0-ml aliquot of culture broth was centrifuged for

97

10 min at 13,000×g. The pellet was extracted with the bacterial DNA/RNA extraction kit

98

(MORA–EXTRACT; Kyokuto Pharmaceuticals). Bacterial cells were mechanically disrupted

99

with zirconia beads, and phenol-chloroform treatment was performed, as recommended by the

100

manufacturer. A 100-µl aliquot of TE buffer (10 mM Tris–HCl, pH 8.0, 0.1 mM EDTA) was

101

added to the extracted DNA pellet, and DNA concentrations were determined using the

102

PicoGreen system (Molecular Probes, Eugene, OR), as recommended by the manufacturer.

103

Amplicor PCR. For MGIT-positive culture, an aliquot of each culture was tested in parallel by

104

the Amplicor PCR (Roche Diagnostic Systems) for M. tuberculosis complex, M. avium and M.

105

intracellurare, as described in the manufacturer’s instructions.

106

DNA sequencing. The 25-µl reaction mixture contained ExTaq HS buffer (Takara Shuzo, Ohtsu,

107

Japan) with 2.0 mM MgCl2, 200 µM of each of the deoxynucleoside triphosphates, 1.0 U of EX

108

Taq HS DNA polymerase, 10 ng of template, 10 pmol of each of the primers SSU–bact–27f

109

(5'–AGA GTT TGA TCM TGG CTC AG–3') and SSU–bact–907r (5'–CCG TCA ATT CMT TTR

110

AGT TT–3') for 16S rDNA, and 16S–1511f (5'–AAG TCG TAA CAA GGT ARC CG–3') and

111

23S–23r (5'–TCG CCA AGG CAT CCA CC–3') for ITS-1 region (18). Amplification was

112

performed with GeneAmp PCR System 9700 ThermalCycler (Applied Biosystems) for 30 cycles

D E

T P

E C

C A

6

113

(30 s at 94°C, 30 s at 53°C, and 90 s at 72°C), followed by an extension step at 72°C for 7 min.

114

The PCR products were visualized with ethidium bromide staining and UV illumination.

115

Purification of the amplicons was performed with the AMPure PCR Purification System

116

(Agencourt, Beverly, MA), following the manufacturer’s instructions. The ABI Prism BigDye

117

Terminator v1.1 Cycle Sequencing Ready Reaction kit (Applied Biosystems) was used for the

118

sequencing of the PCR products. The sequencing reaction mixture contained 0.5 µl of Big Dye

119

premix, 1.75 µl of 5×sequencing buffer, 1.6 pmol of sequencing primer, and approximately 10 ng

120

of PCR product template in a total volume of 10 µl. SSU–bact–27f, SSU–bact–907r, 16S–1511f,

121

and 23S–23r were used for sequencing primers for both DNA strands. The sequencing reaction

122

was performed with a GeneAmp PCR system 9700 thermocycler (Applied Biosystems). A

123

denaturation step at 95°C for 2 min proceeded 25 cycles (10 s at 96°C, 15 s at 53°C, and 2.5 min

124

at 60°C). Sequencing products were purified with a CleanSEQ Sequencing Reaction Clean-Up

125

system (Agencourt) and analyzed with the 3130xl Genetic Analyzer (Applied Biosystems),

126

following the manufacturer’s instructions. Raw sequencing data were edited to resolve

127

discrepancies by evaluating the electrophoretograms with the Sequencing Analysis software v

128

3.3 (Applied Biosystems). The edited sequence data from both strands were aligned with the

129

DNASIS Pro (Hitachi Software Engineering, Yokohama, Japan). We analyzed the consensus

130

sequence of approximately 500 bp of the 5′–end of the 16S rDNA for comparison with the

131

sequence databases stored in GenBank (BLAST; http://www.ncbi.nlm.nih.gov/BLAST/) or the

132

Ribosomal Differentiation of Medical Microorganisms (RIDOM; http://www.ridom–rdna.de/) (9,

133

10).

134

Probe design for Invader assay. The 16S rDNA and ITS-1 sequences were aligned with those

D E

T P

E C

C A

7

135

from the GenBank database and quality-controlled RIDOM database. With Invader Creator

136

software (Third Wave Technologies), 20 specific probes were designed to identify and

137

differentiate mycobacteria in conserved regions of ITS-1 and 16S rDNA hypervariable regions A

138

and B, including species-specific sites. In addition, mixed GNS probes for the mycobacteria

139

genus–specific region and BRB probe for the bacteria universal region were designed from

140

conserved regions of 16S rDNA (Table 1). Signal probes and Invader oligonucleotide for the

141

specific nucleotide sequences were designed to have theoretical annealing temperatures of 63°C

142

and 77°C, respectively, using a nearest-neighbor algorithm on the basis of final probe and target

143

concentrations. The signal probes and Invader oligonucleotides used to detect Mycobacterium

144

species by the Invader assay are shown in Table 1.

145

Biplex Invader assay. The Invader assay utilizes the thermostable flap endonuclease Cleavase

146

XI, which cleaves invasive structures formed from single-base overlap between the Invader

147

oligonucleotide and the signal probe when hybridized to a complementary target DNA. This

148

method can accurately discriminate single-base differences, such as SNPs, and can measure

149

genomic DNA (≥104 copy/assay). The Invader assay combines structure-specific cleavage

150

enzymes and a universal FRET (Förster resonance energy transfer) system, and the biplex format

151

of the Invader assay enables simultaneous detection of two kinds of species in a single well. At

152

first, 3 µl of genomic DNA (0.03–0.33 ng/µl) was added into a 384-well plate, 6 µl of mineral oil

153

(Sigma) was overlayed into all reaction wells, the mixtures were denatured by incubation at 95°C

154

for 10 min, and 3 l of the appropriate reaction mixture was added. The reaction mixture

155

contained 32 ng Cleavase XI enzyme, 0.817 µmol/l of each signal probe, 0.163 µmol/l of each

156

Invader oligonucleotide, 0.65 µmol/l each of FAM dye and Redmond Red dye FRET cassettes

D E

T P

E C

C A

8

157

(Epoch Bioscience, Redmond, WA), 5.04% PEG8000, 30.7 mmol/l MgCl2 and 24.5 mmol/l

158

MOPS. After the reagent was dispensed, the plate was spun for 10 sec at 400×g, then

159

sequentially incubated isothermally at 64°C up to 4 h in the thermal fluorescence microtiter plate

160

reader (Fluodia; Otsuka Electronics, Osaka, Japan), while the fluorescent intensities were

161

measured at 15 min intervals for FAM (excitation: 486 nm; emission: 530 nm) and Redmond

162

Red (RED) (excitation: 560 nm; emission: 620 nm).

163

Invader assay data analysis. Raw data were analyzed using a Microsoft Excel–based

164

spreadsheet (Microsoft, Redmond, WA). For each specific signal, fold-over-zero (FOZ) values

165

were calculated as follows for the signal obtained with each dye:

T P

E C

166 167 168

D E

FOZ = Raw counts from sample/ Raw counts from no target control.

C A

169

DNA samples from 54 mycobacterial reference strains were used to determine the cut-off value

170

of FOZ. The mean + 5 S.D. of the FOZ value of non-target sequence in each well was calculated

171

to 1.22–1.95 (probe set 1–10) of FAM-FOZ and 1.23–1.70 (probe set 1–10) of RED-FOZ.

172

Therefore, the cut-off level was set at 2.00.

173

9

174

RESULTS

175 176

Probe design and validation

177

The most widely accepted gene for bacterial identification is the 16S rDNA, but this gene alone

178

lacks sufficient resolution to identify all mycobacterial species (5, 32, 37, 39). For example, the

179

16S rDNA could not distinguish between M. kansasii and M. gastri, and also between M.

180

chelonae and M. abscessus. However, since the ITS-1 region had greater diversity than the 16S

181

rDNA (27, 18), the Invader probes designed in the ITS-1 region could distinguish these strains.

182

Therefore, the Invader assay was set up with a more effective combination of the 16S rDNA and

183

the ITS-1 region.

D E

T P

E C

184

To validate the Invader probes, we evaluated 65 type and 13 reference strains, and 607

185

mycobacterial clinical strains. Specific signals were obtained for the target sequences of the type

186

and reference strains, according to the criteria of the Invader assay. The GNS and the BRB

187

probes were designed for the mycobacterial genus–specific region and the bacteria universal

188

regions, respectively. Using the Invader assay, strains that reacted only to both the BRB and GNS

189

probes were mycobacteria other than target species, and strains that reacted to only the BRB

190

probe were bacteria other than mycobacteria (Table 2). Next, we confirmed the variation and

191

conservation of target sequences in 607 clinical mycobacterial strains, which were identified by

192

DNA sequencing of the 16S rDNA and ITS-1. For all 607 clinical strains, the identities

193

determined by DNA sequencing corresponded exactly to those determined by the Invader assay

194

(Table 3).

C A

195

10

196

Identification directly from the BACTEC MGIT samples. By examining a serial dilution of

197

reference strains, the detection limit of genomic DNAs for all Invader probes was found to be

198

0.03 ng/µl. DNA extracted from 122 positive samples of the MGIT 960 system had a minimum

199

concentration of < 0.01 ng/µl (less than the lower limit of the PicoGreen system), a maximum

200

value 24.38 ng/µl, and an average of 4.40 ng/µl. Zirconia beads efficiently extracted DNA for M.

201

tuberculosis and NTM. Six MGIT samples were negative in the Invader assay, and the DNA

202

concentrations of four MGIT samples were below the detection limit (< 0.01 ng/l). Although

203

the remaining two MGIT samples had sufficient DNA for the Invader assay (from ≥ 1 ng/l to

Suggest Documents